☰

Andrew S. Dixon, Ph.D.

Affiliations: 
2011 Pharmaceutics and Pharmaceutical Chemistry University of Utah, Salt Lake City, UT 
Area:
Pharmacy, Biochemistry, Oncology
Google:
"Andrew Dixon"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Carol S. Lim grad student 2011 University of Utah
 (Capture of Bcr-Abl for induction of apoptosis in chronic myelogenous leukemia: From inhibition to nuclear escort.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Radford DC, Yang J, Doan MC, et al. (2019) Multivalent HER2-binding polymer conjugates facilitate rapid endocytosis and enhance intracellular drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society
Schwinn MK, Machleidt T, Zimmerman K, et al. (2017) CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide. Acs Chemical Biology
Dixon AS, Kim SJ, Baumgartner BK, et al. (2017) A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays. Scientific Reports. 7: 8186
Binkowski B, Dixon AS, Schwinn MK, et al. (2015) Abstract 1998: A novel luminescent system for monitoring intracellular protein:protein interactions Cancer Research. 75: 1998-1998
Okal A, Mossalam M, Matissek KJ, et al. (2013) A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells. Molecular Pharmaceutics. 10: 3922-33
Dixon AS, Miller GD, Bruno BJ, et al. (2012) Correction to "improved coiled-coil design enhances interaction with bcr-abl and induces apoptosis". Molecular Pharmaceutics. 9: 1535
Dixon AS, Constance JE, Tanaka T, et al. (2012) Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs. Pharmaceutical Research. 29: 1098-109
Dixon AS, Miller GD, Bruno BJ, et al. (2012) Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis. Molecular Pharmaceutics. 9: 187-95
Dixon AS, Pendley SS, Bruno BJ, et al. (2011) Disruption of Bcr-Abl coiled coil oligomerization by design. The Journal of Biological Chemistry. 286: 27751-60
Woessner DW, Dixon AS, Lim CS. (2011) Abstract 1780: Potentiating chronic myeloid leukaemia treatment using oligomeric disruption and RNAi Cancer Research. 71: 1780-1780
See more...